Developing in-licensed immunotherapies for asthma and other indications.
Industry: Health Care
First Day Return: +12.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/21/2018 |
Offer Price | $16.00 |
Price Range $16.00 - $16.00 | |
Offer Shares (mm) | 17.3 |
Deal Size ($mm) | $276 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/07/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $276 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Diego, CA, United States |
Founded | 2015 |
Employees at IPO | 105 |
Website www.gossamerbio.com |